NCT00985673View on ClinicalTrials.gov

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

611

Participants

Timeline

Start Date

October 1, 2009

Primary Completion Date

December 28, 2009

Study Completion Date

December 29, 2010

Conditions
Influenza
Interventions
BIOLOGICAL

GSK2340274A

Two intramuscular injections

BIOLOGICAL

GSK2340273A

Two intramuscular injections

BIOLOGICAL

Seasonal trivalent influenza vaccine (TIV)

Single intramuscular injection

BIOLOGICAL

Saline placebo

Single intramuscular injection

Trial Locations (7)

27612

GSK Investigational Site, Raleigh

30281

GSK Investigational Site, Stockbridge

76135

GSK Investigational Site, Fort Worth

78705

GSK Investigational Site, Austin

B3K 6R8

GSK Investigational Site, Halifax

H2K 4L5

GSK Investigational Site, Montreal

J1H 4J6

GSK Investigational Site, Sherbrooke

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY